
Keywords: Gadolinium chelates; Gadolinium; Contrast agents; Safety; Juvenile toxicity; Immaturity of renal function.GC, gadolinium chelate; PND, postnatal day; MRI, magnetic resonance imaging; CT, computed tomography; NSF, nephrogenic systemic fibrosis; EMA, Europe